Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 topical RLS-1496 cream study in plaque psoriasis or eczema
NL-OMON60637Phase 1Completed
- Sponsor
- Rubedo Life Sciences
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of RLS-1496 in plaque psoriasis and atopic dermatitis (AD), sponsored by Rubedo Life Sciences. Primary endpoint: Primary endpoint(s). Started Apr 2025; status: completed.
02
Drugs
RLS-1496
03
Conditions
plaque psoriasisatopic dermatitis (AD)
Beyond the preview
Go deeper on NL-OMON60637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60637.